Sent: Thursday, April 19, 2012 5:44 PM
Subject: Health Care Reform Bulletin #14
Here is one person's contribution comes from Wikipedia
"The term adverse selection was originally used in insurance. It describes a situation where an individual's demand for insurance (either the propensity to buy insurance, or the quantity purchased, or both) is positively correlated with the individual's risk of loss (e.g. higher risks buy more insurance), and the insurer is unable to allow for this correlation in the price of insurance.[1] This may be because of private information known only to the individual (information asymmetry), or because of regulations or social norms which prevent the insurer from using certain categories of known information to set prices (e.g. the insurer may be prohibited from using information such as gender, ethnic origin, genetic test results, or preexisting medical conditions, the last of which amount to a 100% risk of the losses associated with the treatment of that condition). The latter scenario is sometimes referred to as 'regulatory adverse selection'.[2]
The potentially 'adverse' nature of this phenomenon can be illustrated by the link between smoking status and mortality. Non-smokers, on average, are more likely to live longer, while smokers, on average, are more likely to die younger. If insurers do not vary prices for life insurance according to smoking status, life insurance will be a better buy for smokers than for non-smokers. So smokers may be more likely to buy insurance, or may tend to buy larger amounts, than non-smokers. The average mortality of the combined policyholder group will be higher than the average mortality of the general population. From the insurer's viewpoint, the higher mortality of the group which 'selects' to buy insurance is 'adverse'. The insurer raises the price of insurance accordingly. As a consequence, non-smokers may be less likely to buy insurance (or may buy smaller amounts) than if they could buy at a lower price to reflect their lower risk. The reduction in insurance purchase by non-smokers is also 'adverse' from the insurer's viewpoint, and perhaps also from a public policy viewpoint.[3]
Furthermore, if there is a range of increasing risk categories in the population, the increase in the insurance price due to adverse selection may lead the lowest remaining risks to cancel or not renew their insurance. This leads to a further increase in price, and hence the lowest remaining risks cancel their insurance, leading to a further increase in price, and so on. Eventually this 'adverse selection spiral' might in theory lead to the collapse of the insurance market."
They call this the "Death Spiral" (we have seen this before with early association type plans).
Consumer Directed Health Insurance
Reuters just published an article based on the Towers Watson and National Business Group on Health that highlghts the trend of consumer directed health plans. Regardless of the ruling from the Supreme Court, HDHP and CDHPs are becoming the mainstay of medical plans for employers.
The challenge facing employers is the amount of education and support needed for CDHPs. In the past, employees only needed to know the cost of the plans and the per transaction charges (Co-Pays, Co-Insurance, etc.) CDHPs require a significantly higher level of education before the open enrollment time period, during OE and post enrollment.
Impact
If you clients have not yet implemented a CDHP benefit offering, there is a pretty good chance that they will in the near future. Being involved with the broker/consultant and client early on in the conversation will allow for an education plan and improved communications.
Have a question? Want to learn more about a specific term or commonly used phrase? Send an email or post it on ask.businessolver.com